跳至主要内容
临床试验/NCT01456923
NCT01456923已完成1 期

Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer

Centro Hospitalar Nordeste0 个研究点开始时间: 2011年10月21日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - patients that did not underwent surgery

排除标准

  • - patients that underwent surgery

研究组 & 干预措施

Control (chemotherapy and surgery)

Active Comparator

Patients treated with chemotherapy + surgery

干预措施: surgery (Procedure)

Control (chemotherapy and surgery)

Active Comparator

Patients treated with chemotherapy + surgery

干预措施: Treatment with chemotherapy (Other)

Study

Active Comparator

Patients treated only with chemotherapy

干预措施: Only chemotherapy treatment for study cohort (Other)

研究者

发起方
Centro Hospitalar Nordeste
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana Cadavez Pedro

Principal Investigator

Centro Hospitalar Nordeste

相似试验